Drug delivery systems in oral and transdermal hormone therapies
DOI:
https://doi.org/10.33448/rsd-v11i6.28700Keywords:
Drug Delivery Systems; Transdermal System; Transdermal patch.Abstract
The purpose of any drug delivery system is to deliver appropriate therapeutic amounts of drugs to the body in order to achieve and maintain the desired concentration of the administered substance. The aim of this work to analyze innovations in drug delivery systems by oral and transdermal route by the pharmaceutical industry. It is integrative review of literature, analyzing studies in some databases such as in PubMed, SciELO and LILACS, with the descriptors: drug delivery systems, pharmaceutical industry, hormones, oral and transdermal. The papers selected for the study range from 2000 to 2021, excluding duplicate studies and those that were not related to the topic. The research initially identified 5360 studies, being 5336 of those papers excluded after the application of exclusion criteria. A greater number of studies with the descriptor hormones was observed, substantially greater in the range from 2006 to 2011. There was a greater predominance of transdermals than oral in which concerns selected studies. This information reinforces, therefore, the great advantage of treatments with these types of systems, as they improve the patient's therapy bringing an adequate cure or palliative. In addition, it is also noted that a greater incentive is needed to study these systems orally, providing new insulin therapies, for example, orally, bringing more adherence, without the routine stings.
References
Abramson, A Caffarel-Salvador, E Soares, V Minahan, D Tian, R. Y & Lu, X (2019). A luminal unfolding microneedle injector for oral delivery of macromolecules. Nature Medicine, 25(10), 1512-1518.
Alyautdin, R Khalin, I Nafeeza, MI Haron, M. H., & Kuznetsov, D. (2014). Nanoscale drug delivery systems and the blood–brain barrier. International Journal of Nanomedicine. 9, 795-811.
Ching-ng, L & Gupta, M (2020). Transdermal drug delivery systems in diabetes management: A review. Asian Journal of Pharmaceutical Sciences, 15(1): 13-25.
Chorilli, M., Brizante, A. C., Rodrigues, C. A., & Salgado, H. R. N. (2007). Aspectos gerais em sistemas transdérmicos de liberação de fármacos. Rev. Bras. Farm, 88(1), 7-13.
Doostmohammadi, M Ameri, A Mohammadinejad, R Dehghannoudeh, N Banat, I. N Ohadi, M et al (2019). Hydrogels for peptide hormones delivery: Therapeutic and tissue engineering applications. Drug Design, Development and Therapy, 13, 3405-3418.
Hanbali, O. A. A..., Khan, H. M. S., Sarfraz, M., Arafat, M., Liaz, S., & Hameed, A (2019). Transdermal patches: Design and current approaches to painless drug delivery. Acta Pharm, 69 (2), 197-215.
Jain, D Panda, A. K & Majumdar, D. K (2005). Eudragit S100 Entrapped Insulin Microspheres for Oral Delivery. AAPS PharmSciTech, 6(1), 100-107.
Lammers, T (2013). Smart Drug Delivery Systems: Back to the Future vs. Clinical Reality. Int J Pharm, 454(1), 527-529.
Marwah, H Garg, T Goyal, A. K & Rath, G (2014). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv, 23(2), 564-578.
Massaro, M Cavallaro, G Colletti, CG D’Azzo, G Guernelli, S Lazzara, G et al (2018). Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin. Journal of Colloid and Interface Science, 524, 156-164.
Morishita, M Goto, T Nakamura, K Lowman, A. M Takayama, K & Peppas, N. A (2006). Novel oral insulin delivery systems based on complexation polymer hydrogels: Single and multiple administration studies in type 1 and 2 diabetic rats. J Control Release, 110(3), 587-594.
Morishita, M Lowman, A. M Takayama, K Nagai, T & Peppas, N. A (2002). Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release, 81(1-2), 25-32.
Rajabalaya, R Musa, M. N., Kifli, N & David, S. R (2017). Oral and transdermal drug delivery systems: role of lipid-based lyotropic liquid crystals. Drug Design, Development and Therapy, 11, 393-406.
Regenthal, R Voskanian, M Baumann, F Teichert, J Brätter, C Aigner, A et al (2018). Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation. Drug Design. Development and Therapy, 12, 3653-3664.
Rodriguez-devora, J. I., Ambure, S Shi, Z. D., Yuan, Y., & Sun, W (2012). Physically facilitating drug-delivery systems. Ther Deliv, 1(3), 125–139.
Santini, J Richards, A Scheidt, R Cima, M Langer, R (2000). Microchips as controlled drug-delivery devices. Angew. Chem, 39(14), 2397-2407.
Santos, N. S., & Castanho, M. A. R. B. (2002). Lipossomas: a bala mágica acertou? Química Nova, 25(6b), 1181-1185.
Shah, P Goodyear, B Dholaria, N Puri, V & Michniak-Kohn, B (2021). Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone. Int. J. Mol. Sci, 22, 1-25.
Silva, J. A Apolinário, A. C., Souza, M. S. R., Damasceno, B. P. G. L., & Medeiros, A. C. D (2010). Administração cutânea de fármacos: desafios e estratégias para o desenvolvimento de formulações transdérmicas. Rev. Ciênc. Farm. Básica Apl, 31(3), 125-131.
Sousa, T Silva, M. D., & Carvalho, R. C (2010). Revisão integrativa: o que é e como fazer. Einstein, 8(1), 102-106.
Takeuchi, I Kobayashi, S Hida, Y & Makino, K (2017). Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: Application of enhanced charged nanoparticles with iontophoresis. Colloids and Surfaces B: Biointerfaces, 155, 35-40.
Villanova, J. C. O., Oréfice, R. L., & Cunha, A. S. (2010). Aplicações Farmacêuticas de Polímeros. Polímeros: Ciência e Tecnologia, 20(1), 51-64.
Wilczewska, A Z., Niemirowicz, K., Markiewicz, K. H & Car, H (2012). Nanoparticles as drug delivery systems. Pharmacological Reports, 64, 1020-1037.
Yun, Y. H., Lee, B. K., & Park, K (2015). Controlled Drug Delivery: Historical perspective for the next generation. J Control Release, 219, 2–7.
Zhang, L., & Mao S (2017). Application of quality by design in the current drug development. As. J. Pharm. Sci, 12, 1-8.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Davi Azevedo Ferreira; Ângelo Gabriel Caminha de Sousa; José Guilherme da Silva Santos; Lara Luzia do Vale Alves; Toshiyuki Nagashima Júnior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
